Markets.com Logo

ACUS

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0$
  • Previous Close
    0$
  • 52 Week Change
    --
  • Day Range
    0.00$
  • 52 Week High/Low
    --
  • Dividend Per Share
    --
  • Market cap
    9 283 M$
  • EPS
    0
  • Beta
    -0.158
  • Volume
    --

About

Amicus Therapeutics, Inc. (ACUS.US) is a biotechnology company focused on discovering, developing, and commercializing therapies for rare diseases. Their primary product is Galafold (migalastat), an oral precision medicine for Fabry disease, a rare genetic disorder. The company also has a pipeline of gene therapy and pharmacological chaperone programs targeting other rare diseases. Its stock is publicly traded on the NASDAQ under the ticker symbol ACUS.
Gold hits a new record above $4800: What is gold price prediction for 2026?

Gold hits a new record above $4800: What is gold price prediction for 2026?

Frances Wang|--
Trending tech stocks analysis: Intel stock jumps 12%, NVDA shares up 3%

Trending tech stocks analysis: Intel stock jumps 12%, NVDA shares up 3%

Frances Wang|--
Forex CFD trading platform reviews 2026: markets.com, IG, Avatrade

Forex CFD trading platform reviews 2026: markets.com, IG, Avatrade

Ghko B|--
ARK 21shares Bitcoin ETF (ARKB) analysis: Is ARKB a good investment?

ARK 21shares Bitcoin ETF (ARKB) analysis: Is ARKB a good investment?

Ghko B|--
EV stocks today: TSLA is going down, Lucid (LCID) stock rises, RIVN drops

EV stocks today: TSLA is going down, Lucid (LCID) stock rises, RIVN drops

Ghko B|--
BTC/USD forecast: Bitcoin drops below $92K, will BTC continue to fall?

BTC/USD forecast: Bitcoin drops below $92K, will BTC continue to fall?

Frances Wang|--
Gold and silver prices hit high: Will XAU/USD and XAG/USD continue to rise?

Gold and silver prices hit high: Will XAU/USD and XAG/USD continue to rise?

Frances Wang|--

Factors

Industry Trends: The performance and outlook of the medical technology industry significantly influence ACUS.US's valuation.

Financial Performance: Revenue growth, profitability, and cash flow are key drivers of investor confidence.

Regulatory Environment: Changes in healthcare regulations and approvals impact ACUS.US's market access and growth.

Technological Innovation: Advancements and breakthroughs in medical technology can boost or hinder ACUS.US's competitiveness.

Market Sentiment: General investor optimism or pessimism affects the overall demand and supply of ACUS.US shares.

Competition: The presence and actions of competitors influence ACUS.US's market share and pricing power.

Economic Conditions: Macroeconomic factors such as interest rates and inflation impact investment decisions.

Company News: Announcements regarding product launches, partnerships, and acquisitions can significantly affect the stock price.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--
Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--
Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

Crypto day trading: How to day trade crypto CFDs with markets.com?

Crypto day trading: How to day trade crypto CFDs with markets.com?

Ghko B|--
Leverage trading: Difference between margin calls and forced liquidation

Leverage trading: Difference between margin calls and forced liquidation

Ghko B|--
Futures CFDs trading: What is futures trading, how to trade futures?

Futures CFDs trading: What is futures trading, how to trade futures?

Ghko B|--